SSA
NXGN

Schonfeld Strategic Advisors’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Schonfeld Strategic Advisors’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-174,748
Closed -$4.15M – 2352
2023
Q3 		$4.15M Buy
+174,748
New +$3.29M 0.03% 601
2023
Q1 		– Sell
-15,400
Closed -$289K – 2846
2022
Q4 		$289K Buy
+15,400
New +$297K ﹤0.01% 1816
2020
Q1 		– Sell
-14,084
Closed -$226K – 1618
2019
Q4 		$226K Buy
+14,084
New +$233K 0.01% 1118
2019
Q1 		– Sell
-24,076
Closed -$366K – 1358
2018
Q4 		$366K Buy
+24,076
New +$413K 0.01% 762
2017
Q3 		– Sell
-55,508
Closed -$956K – 812
2017
Q2 		$956K Buy
+55,508
New +$844K 0.1% 289
2016
Q3 		– Sell
-27,141
Closed -$323K – 584
2016
Q2 		$323K Buy
+27,141
New +$365K 0.07% 300

Other funds holding NXGN

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Schonfeld Strategic Advisors's NXGN Position: Q4 2023 in Review

Schonfeld Strategic Advisors sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 174,748 shares — an estimated $4.15M sold.

Schonfeld Strategic Advisors first reported a position in NXGN in Q2 2016 and held it in 6 quarters. The position peaked at $4.15M in Q3 2023. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • Schonfeld Strategic Advisors reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 174,748 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $4.15M.
  • Schonfeld Strategic Advisors first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2016 and held it in 6 quarters.
  • Schonfeld Strategic Advisors's NextGen Healthcare, Inc. Common Stock position peaked at $4.15M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.